Bio-Path Holdings, Inc.
BPTH- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001133818
No open-market purchases or sales by Bio-Path Holdings, Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
13F holders, Q3 2024
Institutional positions in Bio-Path Holdings, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 14
- +2 vs. Q2 2024
- Shares held
- 59.0K
- −81.2K (−57.9%) vs. Q2 2024
- Total value
- $53.5K
- −$226.8K (−80.9%) vs. Q2 2024
- New holders
- 5
- 2 more added
- Sold out
- 3
- 2 more reduced
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BPTH on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 2 | $5.29K |
| Q4 2024 | 22 | $370.1K |
| Q3 2024 | 14 | $53.5K |
| Q2 2024 | 13 | $285.1K |
| Q1 2024 | 10 | $78.6K |
| Q4 2023 | 19 | $276.5K |
| Q3 2023 | 23 | $256.6K |
| Q2 2023 | 18 | $812.0K |
| Q1 2023 | 21 | $793.1K |
| Q4 2022 | 21 | $976.3K |
| Q3 2022 | 19 | $1.47M |
| Q2 2022 | 17 | $1.59M |
| Q1 2022 | 17 | $1.51M |
| Q4 2021 | 17 | $1.70M |
| Q3 2021 | 17 | $2.23M |
| Q2 2021 | 17 | $2.94M |
| Q1 2021 | 19 | $3.31M |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding Bio-Path Holdings, Inc.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Geode Capital Management, LLC | 13,598 | $12.4K | 0.00% | +2,732+25.1% | Added |
| Vanguard Group Inc | 13,502 | $12.3K | 0.00% | 00.0% | Unchanged |
| Virtu Financial LLC | 12,325 | $11.0K | 0.00% | +12,325 | New |
| Citadel Advisors LLC | 10,917 | $9.93K | 0.00% | +10,917 | New |
| Tower Research Capital LLC (TRC) | 3,371 | $3.07K | 0.00% | −362−9.7% | Reduced |
| UBS Group AG | 2,856 | $2.60K | 0.00% | +1,997+232.5% | Added |
| BlackRock, Inc. | 2,381 | $2.17K | 0.00% | +2,381 | New |
| Morgan Stanley | 35 | $32 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 27 | $24 | 0.00% | −19−41.3% | Reduced |
| Group One Trading, L.P. | 21 | $19 | 0.00% | 00.0% | Unchanged |
| EverSource Wealth Advisors, LLC | 10 | $9 | 0.00% | +10 | New |
| Global Retirement Partners, LLC | 4 | $4 | 0.00% | 00.0% | Unchanged |
| Danske Bank A/S | 2 | $2 | 0.00% | +2 | New |
| Allworth Financial LP | 1 | $1 | 0.00% | 00.0% | Unchanged |
| Armistice Capital, LLC | 0 | $0 | 0.00% | −97,000−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −14,085−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| BlackRock Inc. | – | – | – | – | Not filed |